Show simple item record

dc.contributor.authorYusuf, Issa O
dc.contributor.authorParsi, Sepideh
dc.contributor.authorOstrow, Lyle W
dc.contributor.authorBrown, Robert H
dc.contributor.authorThompson, Paul R
dc.contributor.authorXu, Zuoshang
dc.date.accessioned2024-05-24T18:34:26Z
dc.date.available2024-05-24T18:34:26Z
dc.date.issued2024-01-21
dc.identifier.citationYusuf IO, Parsi S, Ostrow LW, Brown RH, Thompson PR, Xu Z. PAD2 dysregulation and aberrant protein citrullination feature prominently in reactive astrogliosis and myelin protein aggregation in sporadic ALS. Neurobiol Dis. 2024 Mar;192:106414. doi: 10.1016/j.nbd.2024.106414. Epub 2024 Jan 21. PMID: 38253209; PMCID: PMC11003460.en_US
dc.identifier.eissn1095-953X
dc.identifier.doi10.1016/j.nbd.2024.106414en_US
dc.identifier.pmid38253209
dc.identifier.urihttp://hdl.handle.net/20.500.14038/53370
dc.description.abstractAlteration in protein citrullination (PC), a common posttranslational modification (PTM), contributes to pathogenesis in various inflammatory disorders. We previously reported that PC and protein arginine deiminase 2 (PAD2), the predominant enzyme isoform that catalyzes this PTM in the central nervous system (CNS), are altered in mouse models of amyotrophic lateral sclerosis (ALS). We now demonstrate that PAD2 expression and PC are altered in human postmortem ALS spinal cord and motor cortex compared to controls, increasing in astrocytes while trending lower in neurons. Furthermore, PC is enriched in protein aggregates that contain the myelin proteins PLP and MBP in ALS. These results confirm our findings in ALS mouse models and suggest that altered PAD2 and PC contribute to neurodegeneration in ALS.en_US
dc.language.isoenen_US
dc.relation.ispartofNeurobiology of Diseaseen_US
dc.relation.urlhttps://doi.org/10.1016/j.nbd.2024.106414en_US
dc.rights© 2024 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by- nc-nd/4.0/).en_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectDeiminationen_US
dc.subjectMyelin degenerationen_US
dc.subjectNeurodegenerationen_US
dc.subjectNeurodegenerative diseaseen_US
dc.subjectNeuroinflammationen_US
dc.subjectProtein aggregationen_US
dc.titlePAD2 dysregulation and aberrant protein citrullination feature prominently in reactive astrogliosis and myelin protein aggregation in sporadic ALSen_US
dc.typeJournal Articleen_US
dc.source.journaltitleNeurobiology of disease
dc.source.volume192
dc.source.beginpage106414
dc.source.endpage
dc.source.countryUnited States
dc.source.countryUnited States
dc.source.countryUnited States
dc.identifier.journalNeurobiology of disease
refterms.dateFOA2024-05-24T18:34:28Z
dc.contributor.departmentBiochemistry and Molecular Biotechnologyen_US
dc.contributor.departmentNeurologyen_US
dc.contributor.departmentRNA Therapeutics Instituteen_US
dc.contributor.departmentThompson Laben_US


Files in this item

Thumbnail
Name:
Publisher version
Thumbnail
Name:
1-s2.0-S0969996124000135-main.pdf
Size:
16.17Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

© 2024 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
Except where otherwise noted, this item's license is described as © 2024 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by- nc-nd/4.0/).